Bernadette Connaughton - Director at HALOZYME THERAPEUTICS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
HALO on Nasdaq
All Insider Reports
All Insider Reports

Bernadette Connaughton - trading volume in the past year for HALOZYME THERAPEUTICS, INC.

Holdings reported by Bernadette Connaughton for HALOZYME THERAPEUTICS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 40,123 $2,818,640 $70.25 05 Jan 2026 Direct
Option to Purchase Common Stock 5,750 01 May 2025 Direct Common Stock

Transactions reported by Bernadette Connaughton for HALOZYME THERAPEUTICS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.